Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Persistent Pain Common After Stroke

By HospiMedica staff writers
Posted on 30 May 2006
A new study reports that patient-reported pain is common shortly after stroke, and the pain may persist for months.

Researchers from Lund University Hospital (Sweden) examined a total of 297 first-time stroke patients who were registered in the Lund stroke register and selected for their ability to complete the visual analog scale (VAS). More...
The researchers examined the prevalence, intensity, and predictors of pain following stroke from the patients' perspectives. VAS scores of 0-30 were defined as no pain or mild pain while scores of 40-100 were considered to be moderate-to-severe pain.

After four months, 96 patients (32%) reported moderate-to-severe pain, 23 had mild pain, and 178 had no pain. Significant predictors of pain included younger age, female sex, higher U.S. National Institutes of Health (NIH) stroke scale score, and higher HbA1c values. At 16 months, 62 patients (21%) had moderate-to-severe pain, 12 patients had mild pain, and 223 had no pain. Pain intensity was more severe at 16 months than at four months, with median VAS scores of 70 and 60, respectively. A correlation was noted between higher pain intensity and female sex, worse geriatric depression scores, better mini-mental state examination score, and higher HbA1c baseline values.

Pain was constant in up to 47% of subjects reporting pain at both follow-up assessments, and was often present in up to 68%, reported Dr. Ann-Cathrin Jonsson and colleagues. Disturbed sleep attributed to pain occurred in at least 49-58% patients with moderate-to-severe pain. At both follow-up periods, up to 50% of patients required temporary rest for pain relief and about 25% obtained pain relief only by changing position. The results were published in the May 2006 issue of the Journal of Neurology, Neurosurgery, and Psychiatry.



Related Links:
Lund University Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.